• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Club Drugs and Novel Psychoactive Substances: The Clinician's Handbook

Club Drugs and Novel Psychoactive Substances: The Clinician's Handbook

9781911623090
163.74 zł
147.36 zł Save 16.38 zł Tax included
Lowest price within 30 days before promotion: 147.36 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Over the last decade many hundreds of new psychoactive drugs have emerged onto illicit markets. This flood of new drugs has led to clinicians being unsure of the rapidly emerging changing evidence base and uncertain of the best approaches to assessment and clinical management. This book provides a concise, accessible summary of these emerging drugs. By categorizing the hundreds of new drugs by their predominant psychoactive effect - sedative, stimulant and hallucinogenic - the book helps clinicians to manage a drug they are unfamiliar with by using their experience of other drugs with similar psychoactive properties. Written for clinicians from across the frontline, from A&E staff to drug treatment professionals, the authors draw on numerous clinical examples from their own clinical experiences to illustrate aspects of assessment and management. Club drugs and novel psychoactive substances will continue to challenge clinicians and this handbook provides readers with an invaluable introduction to this complex area.
Product Details
89411
9781911623090
9781911623090

Data sheet

Publication date
2020
Issue number
1
Cover
paperback
Pages count
150
Dimensions (mm)
122.00 x 186.00
Weight (g)
160
  • Part I:: 1. Introduction 2. What are NPS and Club Drugs and why are they important; 3. A brief history of NPS production and distribution; 4. Drugs classification framework for Club Drugs and NPS; 5. Clinical challenge of Club Drugs and NPS; Part II. Stimulant Drugs; 6. Stimulant drugs:: introduction; 7. Stimulant drugs:: cocaine; 8. Stimulant drugs:: amphetamine-type; 9. Stimulant drugs:: methamphetamine; 10. Stimulant drugs:: MDMA; 11. Stimulant drugs:: synthetic cathinones; Part III. Depressant Drugs; 12. Depressant drugs:: introduction; 13. Depressant drugs:: GHB/GBL; 14. Depressant drugs:: Fentanyl, Fentanyl analogues and other opioid NPS; 15. Depressant drugs:: Benzodiazepine NPS; 16. Depressant drugs:: Ketamine and its anaologues; Part IV. Synthetic Cannabinoid Receptor Agonsits; 17. Synthetic cannabinoid receptor agonists (SCRAs); Part V. Hallucinogens; 18. Hallucinogens; Part VI. Concluding Remarks and References; 19. Concluding Remarks; 20. References.
Comments (0)